All posts by editor1

Analysts’ Perspective: Manitowoc (MTW), Viacom (VIAB), HollyFrontier (HFC)

Brokerage Firm Seaport Global Securities upgraded Manitowoc Co. (NYSE:MTW) shares from Neutral to Buy rating with a price target of $48.

The Manitowoc Co., Inc. designs, manufactures and distributes a line of crawler mounted lattice boom cranes, under the Manitowoc brand.

*

Viacom Inc. (NASDAQ:VIAB) shares were upgraded by analysts at Deutsche Bank from Sell to Hold rating with a price target of $25.

Viacom, Inc. is a global entertainment content company, which connects with audiences through compelling television programs, motion pictures, short-form video, applications, games, brands for consumer products, social media and other entertainment content.

*

Investment Analysts at Argus upgraded HollyFrontier Corp. (NYSE:HFC) shares from Hold to Buy rating.

HollyFrontier Corp. is an independent petroleum refiner and marketer. It engages in the production of high-value light products such as gasoline, diesel fuel, jet fuel and other specialty products.

**

Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://www.crwe.info/disclaimer/

Analysts’ View: NCS Multistage (NCSM), Dick’s Sporting Goods (DKS), Urban Outfitters (URBN)

Investment Analysts at Raymond James upgraded NCS Multistage Holdings Inc. (NASDAQ:NCSM) shares from Outperform to Strong Buy rating.

NCS Multistage Holdings, Inc. is a provider of engineered products and services that facilitate the optimization of oil and natural gas well completions and field development.

*

Dick’s Sporting Goods Inc. (NYSE:DKS) shares were upgraded by analysts at JP Morgan from Neutral to Overweight rating.

Dick’s Sporting Goods, Inc. engages in the retail of extensive assortment of authentic sports equipment, apparel, footwear, and accessories through a blend of associates, in-store services, and unique specialty shop-in-shops.

*

Brokerage Firm Wolfe Research upgraded Urban Outfitters Inc. (NASDAQ:URBN) shares from Peer Perform to Outperform rating with a price target of $30.

Urban Outfitters, Inc. engages in the operation of retail clothing stores.

**

Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://www.crwe.info/disclaimer/

Analysts’ Perspective: Alaska Air (ALK), Boot Barn Holdings (BOOT), Sangamo Therapeutics (SGMO)

Brokerage Firm Raymond James upgraded Alaska Air Group Inc. (NYSE:ALK) shares from Outperform to Strong Buy rating.

Alaska Air Group, Inc. operates as a holding company, which through its subsidiaries, Alaska Airlines, Inc. and Horizon Air Industries, Inc., engages in the provision of air transportation services.

*

Boot Barn Holdings Inc. (NYSE:BOOT) shares were upgraded by analysts at JP Morgan from Neutral to Overweight rating.

Boot Barn Holdings, Inc. engages in the operation of retail chain stores of western and work-related footwear, apparel, and accessories.

*

Investment Analysts at Piper Jaffray upgraded Sangamo Therapeutics Inc. (NASDAQ:SGMO) shares from Neutral to Overweight rating.

Sangamo Therapeutics, Inc. researches and develops transcription factors in the regulation of genes.

**

Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://www.crwe.info/disclaimer/

Analysts’ View: Perrigo (PRGO), Telus (TU), Aaron’s (AAN)

Investment Analysts at RBC Capital Mkts upgraded Perrigo Co. Plc (NYSE:PRGO) shares from Underperform to Sector Perform rating while increasing their price target from $64 to $86.

Perrigo Co. Plc engages in the production of over-the-counter consumer goods and specialty pharmaceutical products.

*

Brokerage Firm RBC Capital Mkts upgraded TELUS Corp. (NYSE:TU) shares from Sector Perform to Outperform rating while increasing their price target from $47 to $51.

TELUS Corp. operates as a telecommunications company.

*

Aaron’s Inc. (NYSE:AAN) shares were upgraded by analysts at Raymond James from Market Perform to Strong Buy rating.

Aaron’s, Inc. retails consumer electronics, computers, residential furniture, household appliances, and accessories.

**

Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://www.crwe.info/disclaimer/

Analysts’ Perspective: ViaSat (VSAT), SAGE Therapeutics (SAGE), James Hardie (JHX)

ViaSat Inc. (NASDAQ:VSAT) shares were upgraded by analysts at Needham from Hold to Buy rating with a price target of $78.

ViaSat, Inc. engages in the provision of fixed and mobile broadband services, advanced satellite and wireless networks and secure networking systems products and services.

*

Brokerage Firm Chardan Capital Markets upgraded Sage Therapeutics Inc. (NASDAQ:SAGE) shares from Neutral to Buy rating while increasing their price target from $60 to $140.

SAGE Therapeutics, Inc. is a clinical-stage biopharmaceutical company.

*

Investment Analysts at Citigroup upgraded James Hardie Industries Plc (NYSE:JHX) shares from Neutral to Buy rating.

James Hardie Industries Plc engages in the manufacturing of fiber cement products and systems for internal and external building construction applications.

**

Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://www.crwe.info/disclaimer/

Analysts’ View: AvalonBay (AVB), Hackett Group (HCKT), Pan American Silver (PAAS)

Investment Analysts at UBS upgraded Avalonbay Communities Inc. (NYSE:AVB) shares from Neutral to Buy rating while increasing their price target from $190 to $206.

AvalonBay Communities, Inc. operates as a real estate investment trust, which engages in the development, redevelopment, acquisition, ownership, and operation of multifamily communities.

*

Brokerage Firm ROTH Capital upgraded Hackett Group Inc. (NASDAQ:HCKT) shares from Neutral to Buy rating.

The Hackett Group, Inc. is a property-based strategic consultancy and leading enterprise firm, which engages in the provision of advisory, benchmarking, and transformation consulting services.

*

Pan American Silver Corp. (NASDAQ:PAAS) shares were upgraded by analysts at B. Riley FBR, Inc. from Neutral to Buy rating with a price target of $21.

Pan American Silver Corp. is a silver mining company, which provides investors with the best investment opportunity to gain real exposure to silver prices.

**

Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://www.crwe.info/disclaimer/

Analysts’ Perspective: T-Mobile US (TMUS), Flowers Foods (FLO), Janus Henderson Group (JHG)

T-Mobile US Inc. (NASDAQ:TMUS) shares were upgraded by analysts at Deutsche Bank from Hold to Buy rating with a price target of $65.

T-Mobile US, Inc. engages in the provision of mobile communications services under the T-Mobile and MetroPCS brands in the U.S., Puerto Rico, and the U.S. Virgin Islands.

*

Brokerage Firm Pivotal Research Group upgraded Flowers Foods Inc. (NYSE:FLO) shares from Hold to Buy rating with a price target of $23.

Flowers Foods, Inc. engages in the manufacture and sale of bakery products.

*

Investment Analysts at Citigroup upgraded Janus Henderson Group PLC (NYSE:JHG) shares from Neutral to Buy rating.

Janus Henderson Group Plc is a holding company, which engages in the provision of asset management services.

**

Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://www.crwe.info/disclaimer/

Analysts’ View: Rio Tinto (RIO), Nabors Industries (NBR), Green Dot (GDOT)

Investment Analysts at Societe Generale upgraded Rio Tinto Plc (NYSE:RIO) shares from Hold to Buy rating.

Rio Tinto Plc is engaged in the business of exploring, mining and processing of mineral resources.

*

Brokerage Firm Jefferies upgraded Nabors Industries Ltd. (NYSE:NBR) shares from Neutral to Buy rating.

Nabors Industries Ltd. owns and operates land-based drilling rig fleet and is a provider of offshore platform work over and drilling rigs in the U.S. and multiple international markets.

*

Green Dot Corp. (NYSE:GDOT) shares were upgraded by analysts at BTIG Research from Neutral to Buy rating with a price target of $65.

Green Dot Corp. is a technology-centric, pro-consumer bank holding company.

**

Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://www.crwe.info/disclaimer/

Analysts’ Perspective: Virtusa (VRTU), Supernus Pharmaceuticals (SUPN), Intra-Cellular Therapies (ITCI)

Virtusa Corp. (NASDAQ:VRTU) shares were upgraded by analysts at Maxim Group from Hold to Buy rating with a price target of $51.

Virtusa Corp. engages in the provision of information technology consulting, technology implementation, and application outsourcing services.

*

Brokerage Firm Stifel upgraded Supernus Pharmaceuticals Inc. (NASDAQ:SUPN) shares from Hold to Buy rating with a price target of $47.

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases.

*

Investment Analysts at SunTrust upgraded Intra-Cellular Therapies Inc. (NASDAQ:ITCI) shares from Hold to Buy rating.

Intra-Cellular Therapies, Inc. is a biopharmaceutical company, which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system, or CNS.

**

Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://www.crwe.info/disclaimer/

Analysts’ View: Conduent (CNDT), Eni S.p.A. (E), P. T. Telekomunikasi (TLK)

Investment Analysts at Cross Research upgraded Conduent Inc. (NYSE:CNDT) shares from Hold to Buy rating.

Conduent, Inc. provides business process services with expertise in transaction-intensive processing, analytics and automation.

*

Brokerage Firm HSBC Securities upgraded Eni SpA (NYSE:E) shares from Hold to Buy rating.

Eni SpA is engaged in the exploration and production of oil and natural gas, processing, transportation, and refining of crude oil, transport of natural gas, storage and distribution of petroleum products, and the production of base chemicals, plastics and elastomers.

*

PT Telekomunikasi Indonesia (NYSE:TLK) shares were upgraded by analysts at Citigroup from Neutral to Buy rating.

PT Telekomunikasi Indonesia Tbk engages in the provision of telecommunications, information, and network services.

**

Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://www.crwe.info/disclaimer/